CONVALESCENT PLASMA

Message

Investigators at Ruby have obtained Institutional Review Board approval to treat patients with convalescent plasma. If you are
interested in treating your patient with convalescent plasma, you must discuss with the investigators (see contact information below) to
determine eligibility and to obtain proper consent.
Convalescent plasma is inventoried only at Ruby. Should a non-Ruby facility request convalescent plasma, please contact the Ruby’s blood
bank to coordinate delivery (such as through UML.
Contact Information
Brian Peppers, D.O.
Aaron Shmookler, M.D.
Lisa Giblin Sutton, Pharm.D.

Test Code

LAB487

Instructions

(BLOOD BANK) Processing Instructions
After thawing product please obtain 3 mL from each unit of plasma and refreeze to -18°C or less. Label with patient's initials, UNIT NUMBER
and your hospital.

Clinical Significance

Patients are eligible to receive convalescent plasma if they meet the following criteria
1. Laboratory confirmed COVID-19
2. Severe or immediately life-threatening COVID-19, for example:
a. Severe disease is defined as one or more of the following:

shortness of breath (dyspnea)
respiratory frequency ≥ 30/min
blood oxygen saturation ≤ 93%
partial pressure of arterial oxygen to fraction of inspired oxygen ratio < 300,
lung infiltrates > 50% within 24 to 48 hours

b. Life-threatening disease is defined as one or more of the following:

respiratory failure
septic shock
multiple organ dysfunction or failure

3. Informed consent provided by the patient or healthcare proxy.

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.